Is Innocan Pharma Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Innocan Pharma Corp (INNO.CN) is currently classified as DOUBTFUL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Innocan Pharma Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Innocan Pharma Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Innocan Pharma Corp?

Muslim investors may consider investing in Innocan Pharma Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Innocan Pharma Corp classified as DOUBTFUL?

Musaffa determines the Shariah status of Innocan Pharma Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Innocan Pharma Corp updated?

The Shariah compliance status of Innocan Pharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Innocan Pharma Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Innocan Pharma Corp?

You can check the latest Shariah compliance status of Innocan Pharma Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INNO.CN Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: October 16, 2025

Report Source: 2025 2nd Quarter Report

Innocan Pharma Corp. Stock Analysis INNO.CN

Canada Health Care Nano Cap Report: Q2, 2025

InnoCan Pharma Corp. operates as a pharmaceutical tech company. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.

Key Statistics of Innocan Pharma Corp (INNO.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD5.19CAD5.19

Today's Open

CAD5.19

Volume

1000.00

P/E Ratio (TTM)

52 Week Range

CAD5.19CAD1,098.50

Market Cap

25.64M

Avg. Volume

595.85

Dividend Yield

Financial Metrics & Statements of Innocan Pharma Corp (INNO.CN)

FAQ's for Innocan Pharma Corp (INNO.CN)

According to Musaffa’s Shariah screening methodology, Innocan Pharma Corp (INNO.CN) is currently classified as DOUBTFUL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.